Intersectionality in Medicine with A/Professor Nada Hamad

PLEASE ENSURE YOU COMPLETE THE FORM BELOW TO REGISTER. IF YOU ONLY ADD IT TO YOUR CALENDAR YOU WON’T BE REGISTERED PROPERLY AND WON’T RECEIVE THE LINK.

What is Intersectionality? Intersectionality is the way that factors such as race, class, gender, disability and sexuality intersect to shape each other within broader structures and processes of power.

Join A/ Professor Nada Hamad as she provides more insight into Intersectionality and the impact it has on our patients and the awareness we should have as nurses. A/Prof Nada Hamad is a senior staff specialist bone marrow transplant, cellular therapies, clinical and laboratory haematologist at St Vincent’s Hospital in Sydney, where she is the director of the haematology clinical trials unit. Nada is an incredibly accomplished haematologist who wears many hats. Nada is an intersectional feminist with an academic interest in gender equity, diversity and inclusion in medicine.

 

There is limited availability for this event, so secure your spot quickly.
This event has already taken place.
Details
Date: Tuesday 18th of April 2023
Time: 10:00am AEST - 12:00pm AEST

Support and information

Contact Lymphoma Australia Today!

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.